The company won the Low CVP’s award for Low Carbon Innovation by an SME at a gala dinner in Milton Keynes where the Master of Ceremonies was actor Robert Llewellyn – a green vehicle enthusiast, best known for his role as Kryten in BBC’s Red Dwarf and for presenting Channel 4′s Scrapheap Challenge.
The award is the first from the motor industry to recognise Celtic Renewables contribution to the effort to lower carbon emissions in the global motor industry. It is one of only 14 awards accredited by the Royal Society for the encouragement of Arts, Manufactures and Commerce (RSA), which qualifies Celtic Renewables for the prestigious EU bi-annual European Business Awards for the Environment.
The judging panel comprised 22 senior executives from across the range of organisations with a stake in the low carbon road transport agenda. Announcing the award the judges commented: “Celtic Renewables’ practice of turning industrial waste into biofuel, solvents and animal feed is an excellent example of an environmentally and commercially sustainable business model. They have taken known technology and adapted it to current market conditions, attracting the investment and partners required to scale up to industrial production.”
Professor Tangney said: “It’s a tremendous honour and fantastic endorsement to win an award from the automotive sector. We have already been widely recognised for the potential impact of our innovation but this award shows our technology has genuine commercial appeal and that the market is both ready and waiting for sustainable biobutanol as an alternative to petrol and diesel.”
Celtic Renewables has already proved the concept of producing biobutanol from draff – the sugar rich kernels of barley which are soaked in water to facilitate the fermentation process necessary for whisky production – and pot ale, the yeasty liquid that is heated during distillation. The company is currently working with Tullibardine distillery to commercialise the process.
Earlier this year, Celtic Renewables signed an agreement with Europe’s foremost biotechnology pilot facility to undergo next stage testing of its process. The partnership, that allows the company to develop its technology at Bio Base Europe’s pilot plant in Ghent, was made possible by second round funding worth £1.2million, including more than £800,000 from the UK Government, to help meet its ambition of growing a new £100 million-a-year industry in the UK.